SCHEMBL24801477

SCHEMBL24801477

c1ccc(-c2ccc(N(c3ccccc3)c3ccc(-c4nc(-c5cc(-c6ccccc6)c6oc7cc8ccccc8cc7c6c5)c5ccccc5n4)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
PDK1 Q15118 2/20 0.35
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
PDE5A O76074 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GLA P06280 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24255576 0.96 MEN1 (0.40) MEN1KMT2AATMPDK1KDM4E
SCHEMBL24255570 0.95 MEN1 (0.41) MEN1KMT2AATMPDK1KDM4E
SCHEMBL24801575 0.94 MEN1 (0.39) MEN1KMT2AATMPDK1KDM4E
SCHEMBL23609723 0.93 MEN1 (0.34) MEN1KMT2AATMPDK1CYP1A2
SCHEMBL24802767 0.89 MEN1 (0.35) MEN1KMT2AATMPDK1KDM4E
SCHEMBL24802732 0.89 NUDT1 (0.38) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL23597143 0.89 MEN1 (0.36) MEN1KMT2AATMPDK1KDM4E
SCHEMBL24255574 0.88 ALDH1A1 (0.33) MEN1KMT2AKDM4ECYP1A2CYP3A4
SCHEMBL24255573 0.87 MEN1 (0.39) MEN1KMT2AATMPDK1KDM4E
SCHEMBL24255575 0.87 KMT2A (0.37) MEN1KMT2AKDM4ECYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411411-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT LT MATERIALS CO.,LTD. (KR) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411411-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT CRY1, ODC1, ORC3 MEN1 504/4885KMT2A 1451/4885ATM 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.